Table 1.
The clinical characteristics and the results of treatment with salvia and the control (mean ± SD or CI 95%)
| Salvia group | Control group | P | |
|---|---|---|---|
| Maternal ages (year old) | 28.3 ± 2.2 [23.9, 32.7] |
28.5 ± 2.3 [23.9, 33.1] |
NS |
| Gestational age (weeks) | 32.0 ± 3.5 [25.0, 39.0] |
31.1 ± 3.7 [23.7, 38.5] |
NS |
| Amniotic fluid index (cm) | |||
| Pretreatment | 4.9 ± 2.3* [1.3, 10.5] |
5.1 ± 2.1 [0.9, 9.3] |
NS |
| Post-treatment | 7.1 ± 2.4 [2.3, 11.9] |
5.5 ± 3.1 [0, 11.7] |
S |
| Duration of therapy (days) | 7.2 ± 2.7 [1.8, 12.6] |
6.9 ± 3.8 [0.14.5] |
NS |
| Increased velocity (cm/day) | 0.18 ± 0.06 [0.02, 0.30] |
0.05 ± 0.02 [0.01, 0.09] |
S |
| Absolute efficacy rate | 70(30/43)% | 24.4(10/44)% | S |
| Relative efficacy rate | 84(36/43)% | 36.6(15/41)% | S |
Notes: In the salvia group, the amniotic fluid index was significantly increased post-treatment compared with pretreatment (paired t = 3.62, p < 0.005).